Wide impairment of cerebral serotoninergic activity but inter-individual heterogeneity in bulimia nervosa patients: A pilot [18F]MPPF/PET study

World Journal of Biological Psychiatry

Volumn 15, Issue 8, 2014, Pages 599-608

  Galusca, Bogdan ^a   Sigaud, Torrance ^a   Costes, Nicolas ^b   Redoute, Jerome ^b   Massoubre, Catherine ^a   Estour, Bruno ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b CERMEP IMAGERIE DU VIVANT   (France)

Author keywords

Brain imaging; Depression; Eating disorders; PET; Serotonin receptor

Indexed keywords

PIPERAZINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SEROTONIN DERIVATIVE; UNCLASSIFIED DRUG; [4 (2 METHOXYPHENYL) 1 [2 (N 2 PYRIDINYL) PARA FLUOROBENZAMIDO] ETHYLPIPERAZINE] F 18; 4-(2' METHOXYPHENYL)-1-(2'-(N-(2''-PYRIDINYL)-4-FLUOROBENZAMIDO)ETHYL)PIPERAZINE; AMINOPYRIDINE DERIVATIVE;

ADULT; ARTICLE; BRAIN ASYMMETRY; BRAIN DISEASE; BRAIN FUNCTION; BRAIN MAPPING; BULIMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; FEEDING BEHAVIOR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; INSULA; LIMBIC CORTEX; NUCLEAR MAGNETIC RESONANCE SCANNER; PARIETAL CORTEX; PET SCANNER; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; RAPHE NUCLEUS; RECEPTOR AFFINITY; SEROTONINERGIC ACTIVITY; SEROTONINERGIC SYSTEM; TEMPORAL CORTEX; VOXEL BASED MORPHOMETRY; ADOLESCENT; BRAIN; CASE CONTROL STUDY; DIAGNOSTIC USE; NEUROIMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; SEROTONINERGIC NERVE CELL; TEMPORAL LOBE; YOUNG ADULT;

ADOLESCENT; ADULT; AMINOPYRIDINES; BRAIN; BULIMIA NERVOSA; CASE-CONTROL STUDIES; HUMANS; LIMBIC LOBE; NEUROIMAGING; PILOT PROJECTS; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; RAPHE NUCLEI; SEROTONERGIC NEURONS; TEMPORAL LOBE; YOUNG ADULT;

EID: 84911484238     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2014.942358     Document Type: Article

References (58)

1. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association.
2. Andreason PJ , Altemus M , Zametkin AJ , King AC , Lucinio J , Cohen RM. 1992. Regional cerebral glucose metabolism in bulimia nervosa. Am J Psychiatry 149 : 1506-1513.
3. Bailer UF , Bloss CS , Frank GK , Price JC , Meltzer CC , Mathis CA , et al. 2011. 5-HT(1)A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups. Int J Eat Disord 44 : 477-487.
4. Bailer UF , Frank GK , Henry SE , Price JC , Meltzer CC , Becker C , et al. 2007a. Serotonin transporter binding after recovery from eating disorders. Psychopharmacology (Berlin) 195 : 315-324.
5. Bailer UF , Frank GK , Henry SE , Price JC , Meltzer CC , Mathis CA , et al. 2007b. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol Psychiatry 61 : 1090-1099.
6. Bailer UF , Frank GK , Henry SE , Price JC , Meltzer CC , Weissfeld L , et al. 2005. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C] WAY-100635. Arch Gen Psychiatry 62 : 1032-1041.
7. Bailer UF , Frank GK , Price JC , Meltzer CC , Becker C , Mathis CA , et al. 2013. Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa. Psychiatry Res 211 : 160-168.
8. Bencherif B , Guarda AS , Colantuoni C , Ravert HT , Dannals RF , Frost JJ. 2005. Regional mu-opioid receptor binding in insular cortex is decreased in bulimia nervosa and correlates inversely with fasting behavior. J Nucl Med 46 : 1349-1351.
9. Blanke O , Mohr C , Michel CM , Pascual-Leone A , Brugger P , Seeck M , et al. 2005. Linking out-of-body experience and self processing to mental own-body imagery at the temporoparietal junction. J Neurosci 25 : 550-557.
10. Brooks SJ , O ' Daly OG , Uher R , Friederich HC , Giampietro V , Brammer M , et al. 2011. Differential neural responses to food images in women with bulimia versus anorexia nervosa. PLoS One 6 : e22259.
11. Cooper Z , Fairburn CG. 1987. The Eating Disorders Examination: a semistructured interview for the assessment of the specifi c psychopathology of eating disorders. Int J Eat Disord 6 : 1-8.
12. Costes N , Merlet I , Ostrowsky K , Faillenot I , Lavenne F , Zimmer L , et al. 2005. A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. J Nucl Med 46 : 1980-1989.
13. Costes N , Merlet I , Zimmer L , Lavenne F , Cinotti L , Delforge J , et al. 2002. Modeling [18F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection. J Cereb Blood Flow Metab 22 : 753-765.
14. Delvenne V , Goldman S , De Maertelaer V , Lotstra F. 1999. Brain glucose metabolism in eating disorders assessed by positron emission tomography. Int J Eat Disord 25 : 29-37.
15. Derogatis LR. 1983 Clinical Psychometric Research, Towson, MD, USA.
16. Downing PE , Jiang Y , Shuman M , Kanwisher N. 2001. A cortical area selective for visual processing of the human body. Science 293 : 2470-2473.
17. Estour B , Germain N , Diconne E , Frere D , Cottet-Emard JM , Carrot G , et al. 2010. Hormonal profi le heterogeneity and short-term physical risk in restrictive anorexia nervosa. J Clin Endocrinol Metab 95 : 2203-2210.
18. Faris PL , Kim SW , Meller WH , Goodale RL , Oakman SA , Hofbauer RD , et al. 2000. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial. Lancet 355 : 792-797.
19. Galusca B , Costes N , Zito NG , Peyron R , Bossu C , Lang F , et al. 2008. Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [18F]MPPF PET scan study. Biol Psychiatry 64 : 1009-1013.
20. Garavan H , Pankiewicz J , Bloom A , Cho JK , Sperry L , Ross TJ , et al. 2000. Cue-induced cocaine craving: neuroanatomical specifi city for drug users and drug stimuli. Am J Psychiatry 157 : 1789-1798.
21. Garner DM , Olmstead MP , Polivy J. 1983. Development and validation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int J Eat Disord 2 : 15-34.
22. Gerard N , Pieters G , Goffi n K , Bormans G , Van Laere K. 2011. Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa. Biol Psychiatry 70 : 777-784.
23. Ginovart N , Hassoun W , Le Bars D , Weissmann D , Leviel V. 2000. In vivo characterization of p-[(18)F]MPPF, a fl uoro analog of WAY-100635 for visualization of 5-HT(1a) receptors. Synapse 35 : 192-200.
24. Goethals I , Vervaet M , Audenaert K , Van de Wiele C , Ham H , Vandecapelle M , et al. 2004. Comparison of cortical 5-HT2A receptor binding in bulimia nervosa patients and healthy volunteers. Am J Psychiatry 161 : 1916.
25. Goldman-Rakic PS , Selemon LD , Schwartz ML. 1984. Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience 12 : 719-743.
26. Hume S , Hirani E , Opacka-Juffry J , Myers R , Townsend C , Pike V , et al. 2001. Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis nd PET after fenfl uramine. Synapse 41 : 150-159.
27. Jimerson DC , Lesem MD , Kaye WH , Brewerton TD. 1992. Low serotonin and dopamine metabolite concentrations in cerebrospinal fl uid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 49 : 132-138.
28. Kabani N , MacDonald DJ , Holmes CJ , Evans AC. 1998. 3D anatomical atlas of the human brain. Neuroimage 7(Suppl 4, Pt 2) : S717.
29. Kaye W , Gendall K , Strober M. 1998. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biol Psychiatry 44 : 825-838.
30. Kaye WH , Frank GK , Bailer UF , Henry SE , Meltzer CC , Price JC , et al. 2005. Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiol Behav 85 : 73-81.
31. Kaye WH , Frank GK , Meltzer CC , Price JC , McConaha CW , Crossan PJ , et al. 2001. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatry 158 : 1152.
32. Kaye WH , Gendall KA , Fernstrom MH , Fernstrom JD , McConaha CW , Weltzin TE. 2000. Effects of acute tryptophan depletion on mood in bulimia nervosa. Biol Psychiatry 47 : 151-157.
33. Levitan RD , Kaplan AS , Joffe RT , Levitt AJ , Brown GM. 1997. Hormonal and subjective responses to intravenous metachlorophenylpiperazine in bulimia nervosa. Arch Gen Psychiatry 54 : 521-527.
34. Marazziti D , Macchi E , Rotondo A , Placidi GF , Cassano GB. 1988. Involvement of serotonin system in bulimia. Life Sci 43 : 2123-2126.
35. Marsh R , Horga G , Wang Z , Wang P , Klahr KW , Berner LA , et al. 2011. An FMRI study of self-regulatory control and confl ict resolution in adolescents with bulimia nervosa. Am J Psychiatry 168 : 1210-1220.
36. Marsh R , Steinglass JE , Gerber AJ , Graziano O ' Leary K , Wang Z , Murphy D , et al. 2009. Defi cient activity in the neural systems that mediate self-regulatory control in bulimia nervosa. Arch Gen Psychiatry 66 : 51-63.
37. Merlet I , Ryvlin P , Costes N , Dufournel D , Isnard J , Faillenot I , et al. 2004. Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. Neuroimage 22 : 886-896.
38. Mohr HM , Roder C , Zimmermann J , Hummel D , Negele A , Grabhorn R. 2011. Body image distortions in bulimia nervosa: investigating body size overestimation and body size satisfaction by fMRI. Neuroimage 56 : 1822-1831.
39. Naqvi NH , Rudrauf D , Damasio H , Bechara A. 2007. Damage to the insula disrupts addiction to cigarette smoking. Science 315 : 531-534.
40. Nozoe S , Naruo T , Yonekura R , Nakabeppu Y , Soejima Y , Nagai N , et al. 1995. Comparison of regional cerebral blood fl ow in patients with eating disorders. Brain Res Bull 36 : 251-255.
41. Phillips ML , Drevets WC , Rauch SL , Lane R. 2003. Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry 54 : 504-514.
42. Pichika R , Buchsbaum MS , Bailer U , Hoh C , Decastro A , Buchsbaum BR , et al. 2012. Serotonin transporter binding after recovery from bulimia nervosa. Int J Eat Disord 45 : 345-352.
43. Ro O , Martinsen EW , Hoffart A , Rosenvinge JH. 2003. Short-term follow-up of severe bulimia nervosa after inpatient treatment. Eur Eat Disord Rev 11 : 405-417.
44. Scherag S , Hebebrand J , Hinney A. 2010. Eating disorders: the current status of molecular genetic research. Eur Child Adolesc Psychiatry : 1-16.
45. Schienle A , Sch ä fer A , Hermann A , Vaitl D. 2009. Binge-eating disorder: reward sensitivity and brain activation to images of food. Biol Psychiatry 65 : 654-661.
46. Shapiro JR , Berkman ND , Brownley KA , Sedway JA , Lohr KN , Bulik CM. 2007. Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord 40 : 321-336.
47. Sibon I , Benkelfat C , Gravel P , Aznavour N , Costes N , Mzengeza S , et al. 2008. Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fl uoxetine: a positron-emission tomography study in healthy volunteers. Biol Psychiatry 63 : 1135-1140.
48. Smith KA , Fairburn CG , Cowen PJ. 1999. Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch Gen Psychiatry 56 : 171-176.
49. Steiger H. 2004. Eating disorders and the serotonin connection: state, trait and developmental effects. J Psychiatry Neurosci 29 : 20-29.
50. Stephan E , Pardo JV , Faris PL , Hartman BK , Kim SW , Ivanov EH , et al. 2003. Functional neuroimaging of gastric distention. J Gastrointest Surg 7 : 740-749.
51. Tataranni PA , Gautier JF , Chen K , Uecker A , Bandy D , Salbe AD , et al. 1999. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci USA 96 : 4569-4574.
52. Tauscher J , Pirker W , Willeit M , de Zwaan M , Bailer U , Neumeister A , et al. 2001. [123I]beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervos a. Biol Psychiatry 49 : 326-332.
53. Tiihonen J , Keski-Rahkonen A , Lopponen M , Muhonen M , Kajander J , Allonen T , et al. 2004. Brain serotonin 1A receptor binding in bulimia nervosa. Biol Psychiatry 55 : 871-873.
54. Uher R , Yoganathan D , Mogg A , Eranti SV , Treasure J , Campbell IC , et al. 2005. Effect of left prefrontal repetitive transcranial magnetic stimulation on food craving. Biol Psychiatry 58 : 840-842.
55. Van den Eynde F , Claudino AM , Mogg A , Horrell L , Stahl D , Ribeiro W , et al. 2010. Repetitive transcranial magnetic stimulation reduces cue-induced food craving in bulimic disorders. Biol Psychiatry 67 : 793-795.
56. Van Strien T , Friejters JE , Bergers GPA , Defares PB. 1986. The Dutch Eating Behavior Questionnaire for assessment os restrained, emotional and external eating behavior. Int J Eat Disord 5 : 295-315.
57. Zimmer L , Mauger G , Le Bars D , Bonmarchand G , Luxen A , Pujol JF. 2002. Effect of endogenous serotonin on the binding of the 5-hT1A PET ligand 18F-MPPF in the rat hippocampus: kinetic beta measurements combined with microdialysis. J Neurochem 80 : 278-286.
58. Zimmer L , Rbah L , Giacomelli F , Le Bars D , Renaud B. 2003. A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus. J Nucl Med 44 : 1495-1501.